Simulations Plus (SLP) Tops Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Simulations Plus Reports FY2016 and Fourth Quarter FY2016 Financial Results
November 11, 2016 4:01 PM EST
Full Fiscal Year Pharmaceutical Software and Services Up 9.1%;
Earnings
per share $0.29, up 27.5% over prior year
LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of software for pharmaceutical discovery and development, today reported its financial results for its 2016 fiscal year (FY16) and fourth quarter (4Q16) ended August 31, 2016.
Results for the 2016 fiscal year (FY16):
Revenues were $19.97 million, representing an increase of 9.1% over $18.31 million in FY15 Gross profit was up 10.4% to $15.4 million, an increase of $1.45 million from... More